Core Viewpoint - The overall trend of acute respiratory infectious diseases in China is currently declining, as reported by the Chinese Center for Disease Control and Prevention (CDC) [1]. Group 1: Current Situation of Respiratory Diseases - The CDC is continuously monitoring flu-like cases and severe acute respiratory infection cases in hospitals across the country [1]. - The positive detection rates for respiratory samples in sentinel hospitals show that the top three pathogens are influenza virus, respiratory syncytial virus, and rhinovirus, all of which are known common pathogens [1]. - There have been no discoveries of unknown pathogens or new infectious diseases related to these respiratory infections [1]. Group 2: Flu Trends and Statistics - The current flu epidemic in China is at a low level, with a continuous decline over the past two months [1]. - The positive detection rate of influenza virus, the number of reported cases, and the number of reported outbreaks are all on a downward trend [1]. - The predominant circulating strain is the H3N2 subtype of influenza A, while the proportion of the Victoria lineage of influenza B has shown a slight increase [1]. Group 3: Other Respiratory Pathogens - The positive detection rate for respiratory syncytial virus is also declining, with higher rates observed in northern provinces compared to southern provinces [1]. - The positive detection rate for rhinovirus is fluctuating at a certain level [1]. - The detection rates for other monitored respiratory pathogens, including the novel coronavirus, remain low overall [1].

Core Viewpoint - The article discusses the current flu season in China, emphasizing that the flu virus's evolutionary capability has not increased, despite a rise in flu cases. The seasonal flu is attributed to antigenic drift rather than enhanced virus evolution [4]. Group 1: Flu Season Overview - The flu is expected to peak in mid-December, with the H3N2 subtype being the dominant strain, accounting for over 95% of cases [6]. - Recent data indicates that the flu positivity rate among tested cases is rising, particularly in children and adolescents, but overall patient visits remain consistent with previous years, keeping flu activity within seasonal limits [6]. - As of December 5, 17 provinces in China are experiencing high levels of flu activity, while others are at moderate levels [6]. Group 2: Historical Context and Current Statistics - The current flu season is noted to have started earlier than the previous one, with activity levels slightly exceeding last year's peak [6]. - According to the China CDC, the percentage of flu-like cases reported in emergency departments was 9.6% in the 48th week, with a flu positivity rate of 51.1% among those cases, which has not surpassed the highest levels seen in the past three years [6][8]. - The monitoring of flu cases is based on symptoms such as fever, cough, and sore throat, with 51% of sampled cases showing flu virus infection, indicating a targeted approach rather than a general population infection rate [7][8].

Core Insights - The ongoing flu season in China is experiencing a rise in cases, but the evolution capability of the flu virus is not necessarily stronger than before [1][2] - The H3N2 subtype of the flu virus is currently dominant, accounting for over 95% of cases [1] - The flu activity level this season has slightly exceeded last year's peak, with a notable increase in positive cases among children and adolescents [2] Group 1 - The flu virus undergoes antigenic drift, which causes seasonal outbreaks, but this does not indicate an increase in its evolutionary strength [1] - Recent monitoring suggests that flu cases may peak in mid-December, with 17 provinces experiencing high levels of flu activity [1] - The overall number of flu cases remains within seasonal limits, with the positivity rate for flu tests rising, particularly among younger patients [1][2] Group 2 - The flu-like illness cases reported in hospitals accounted for 9.6% of total emergency visits, with a positivity rate of 51.1% among these cases [2] - The monitoring of flu cases is based on symptoms such as fever, cough, and sore throat, with a focus on the proportion of flu virus detected in sampled cases [2] - The current flu season is noted to be earlier than previous seasons, with comparisons made to the severe flu season of late 2017 to early 2018 [2]

Core Viewpoint - The study highlights the significant impact of respiratory viral infections, such as influenza and SARS-CoV-2, on the awakening and proliferation of dormant disseminated cancer cells (DCC) in the lungs, which may lead to increased cancer-related mortality and metastasis risk [3][14][15]. Group 1: Research Findings - Influenza and SARS-CoV-2 infections can cause dormant DCC in the lungs to awaken, leading to rapid proliferation and metastasis [3][4]. - The research indicates that the presence of interleukin-6 (IL-6) is crucial for the reactivation of DCC, as its levels increase following viral infection [9][12]. - CD4+ T cells play a necessary role in maintaining the awakened state of DCC, although they are not required to initiate this process [12][14]. Group 2: Clinical Implications - The study found that cancer patients infected with SARS-CoV-2 have a significantly higher risk of cancer-related death and lung metastasis compared to those who are not infected [14][15]. - The findings suggest a potential link between respiratory infections and the recurrence of metastatic cancer, emphasizing the need for further exploration in this area [4][15]. Group 3: Mechanisms of Action - The research demonstrated that CD4+ T cells limit the ability of CD8+ T cells to control DCC growth, indicating a complex interplay between different immune cell types in the context of viral infections and cancer [12][14]. - The study also explored the role of inflammation caused by respiratory infections in influencing dormant cancer cells, which had not been a primary focus in previous research [7][8].

Core Insights - The recent rise in COVID-19 cases has drawn public attention, particularly following the announcement of singer Eason Chan's infection, indicating a potential resurgence of the virus in the population [1][2]. Summary by Sections COVID-19 Case Trends - In March 2025, a total of 56,286 new confirmed COVID-19 cases were reported across 31 provinces, with 131 severe cases and 7 deaths attributed to underlying health conditions combined with COVID-19 [2]. - The positivity rate for COVID-19 among influenza-like illness cases increased from 3.5% in the 10th week of 2025 to 6.3% by the end of March [2]. Variants and Mutations - The dominant COVID-19 variants in China have undergone multiple changes over the past two and a half years, transitioning from BA.5.2 and BF.7 to XDV and its sub-variants [1][3]. - The emergence of new variants with immune evasion capabilities has contributed to the re-infection of individuals and the occurrence of new infection peaks [3][4]. Seasonal Patterns and Infection Dynamics - Unlike typical respiratory viruses that peak in winter and spring, COVID-19 has shown a tendency to have peaks in summer as well, suggesting that its spread is more influenced by variant mutations and population immunity rather than seasonal changes [4][5]. - The current dominant variant, XDV and its sub-variant NB.1.8.1, has shown significant transmission advantages, affecting not only mainland China but also regions like Hong Kong, Macau, Japan, and South Korea [6]. Symptoms and Severity - The currently circulating variants have not shown new symptoms; common symptoms remain fever, sore throat, cough, and muscle pain, with a low proportion of severe cases overall [5][6].